Emrullah Yilmaz MD, PhD
@YilmazMDPhD
Followers
618
Following
1K
Media
106
Statuses
512
New York in 2010 and Cleveland in 2024 It was a dream come true to work with @GeneCollector again…
2
3
42
Today I am honored and thrilled to launch the Women’s Comprehensive Health and Research Center, dedicated to helping women during midlife & beyond easily access care. I will serve as its chief visionary & strategic advisor, and I could not be more excited that after all our work,
41
209
2K
I am so sorry I missed this lecture Dr. @ayalamanMD ! This is the stuff of #Heros and #Legends in #MedEd !Thank-you for expertise! @CCF_IMCHIEFS @ccfhemonc @jamecancerdoc @ChrisWeeMD @dbasali
1
3
31
We are so excited for this year’s @ClevelandClinic #radonc #residencymatch! Welcome class of 2029!!! #CleClinicCancer
2
12
53
Please join the AHNS webinar. We have an amazing group of trailblazing researchers giving us insight to the science and clinical applications of immunotherapy in head and neck cancer. @KaramLab @DrUppaluri @CarissaMThomas1 @BcellBruno
@AHNSinfo Basic & Translational Science Committee of the Research Division presents a free webinar "Immunotherapy for Mucosal HNC - Discussion of the Current Landscape & Visions for the Future" Wednesday, March 27, 2024 7:00pm EST /4:00pm PST Register: https://t.co/Z5IS7CMSxF
0
4
11
Looking forward to semifinals at Squash In The Land @PSAWorldTour My daughter getting instructions before the game for volunteering at glass court… It is exciting…
2
1
9
The end of a long journey… To the new chapters… @n8pennell any suggestions for the next series?
2
0
5
Final day of #HNCS24 @RettigEleni discussing surveillance using biomarkers for HPV associated OPX cancer. Great review of rigorous testing required for these biomarkers. We also saw earlier in meeting how negative post-op TTMV was not effective for avoiding adj RT.
2
4
19
FDA approved amivantamab-vmjw for EGFR exon 20 insertion-mutated non-small cell lung cancer indications. https://t.co/pK6ougbaC8
#OCENewsBurst #lcsm #nsclc
fda.gov
On March 1, 2024, the FDA approved amivantamab-vmjw (Rebrevant, Janssen Biotech, Inc.) with carboplatin and pemetrexed.
2
11
27
cSCC session #HNCS24 moderated by @JLGeigerMD and first talk by @ShlomoKoyfmanMD from our head&neck group @ClevelandClinic
0
1
14
Superstar resident @OrlandMarkMD presenting our MRD data for high-risk head&neck cancer patients at #HNCS24 @mattstewart @CCF_IMCHIEFS
0
6
24
First talk @ASTRO_org #HNCS24 by @DrHaddadRobert including summary of novel EGFR targeted trials. Great to have both of these trials available for our patients at @ClevelandClinic
0
1
3
Heading to @ASTRO_org Head&Neck Symposium with @nataliesilvermd @NeilWoodyMD Med onc, rad onc, head&neck surgeon on same flight… Great start for a multidisciplinary symposium :)
2
3
32